Abstract
High-risk patients with antiphospholipid syndrome (APS) experience increased risk of thrombosis when treated with direct oral anticoagulant (DOAC) therapy compared with warfarin. It is essential to establish the APS diagnosis to choose therapy and determine treatment duration. It requires testing for antiphospholipid antibodies, including lupus anticoagulant (LAC). In this viewpoint, we discuss the options for timing of LAC testing, which includes testing before starting anticoagulant treatment (DOAC or warfarin), after switching to heparin or after withdrawal of anticoagulant treatment. DOACs interfere with LAC testing and recommendations emerge stating not to conduct on-therapy LAC testing. All approaches are to some extent currently practised, but have limitations and the area is therefore seemingly a catch 22. We put forward that the anticoagulant effect of DOAC can be eliminated in the laboratory and therefore patients can be tested on-therapy. While it may not eliminate all cases of interference, it could aid the interpretation in these situations and this approach is attractive from the patient and clinician's perspective. Nevertheless, to prevent misdiagnosis the diagnostic workup for APS requires collaboration between ...Continue Reading
References
Sep 9, 2005·American Journal of Clinical Pathology·Jonathan R Genzen, Jonathan L Miller
Jan 20, 2006·Journal of Thrombosis and Haemostasis : JTH·S MiyakisS A Krilis
Jul 25, 2009·Journal of Thrombosis and Haemostasis : JTH·V PengoUNKNOWN Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the Interna
Jul 19, 2011·Blood·Vittorio PengoSabino Iliceto
Apr 29, 2015·Lupus·J Ruinemans-KoertsM M C Hovens
Sep 12, 2015·Lupus·S A JustP Just Vinholt
Apr 15, 2016·Thrombosis and Haemostasis·Franz RatzingerPeter Quehenberger
Aug 30, 2016·The Lancet. Haematology·Hannah CohenUNKNOWN RAPS trial investigators
May 28, 2017·Lupus·G W MooreJ Amiral
Jun 24, 2017·Thrombosis and Haemostasis·Aleksandra AntovicJovan Antovic
Feb 7, 2018·Thrombosis Research·T ExnerM Ahuja
Mar 25, 2018·International Journal of Laboratory Hematology·M JacqueminP Verhamme
Apr 9, 2018·Thrombosis Research·T FliederI Birschmann
Jul 14, 2018·Blood·Vittorio PengoAlessandra Banzato
Nov 24, 2018·International Journal of Laboratory Hematology·Sean Platton, Christina Hunt
Dec 19, 2018·The Lancet. Haematology·Corinne Frere, Dominique Farge
Jan 23, 2019·Pathology·Emmanuel J FavaloroLeonardo Pasalic
Feb 15, 2019·Clinical Chemistry and Laboratory Medicine : CCLM·Michał ZąbczykAnetta Undas
Jun 4, 2019·Thrombosis Research·Emmanuel J FavaloroRoss Baker
Jun 30, 2019·TH Open : Companion Journal to Thrombosis and Haemostasis·Julien FavresseFrançois Mullier
Jul 5, 2019·Journal of Thrombosis and Haemostasis : JTH·Hannah CohenUNKNOWN International Society for Thrombosis and Haemostasis Scientific and Standardization Committee for Lupus Anticoagulant/Antiph
Jul 11, 2019·British Journal of Haematology·Sally Cox-MortonWill Thomas
Sep 17, 2019·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·L SlavikM Palova
Oct 28, 2019·Autoimmunity Reviews·Hagit PelegGentian Denas
Nov 12, 2019·Thrombosis Research·Georges JourdiIsabelle Gouin-Thibault